Literature DB >> 30962757

Usefulness of Preoperative 18F-FDG PET/CT for Patients with Thymic Epithelial Tumors.

Mana Ishibashi1, Yoshio Tanabe1, Hiroto Yunaga1, Hidenao Miyoshi1, Ken Miwa2, Hiroshige Nakamura2, Shinya Fujii1, Toshihide Ogawa1.   

Abstract

BACKGROUND: The purpose of this study was to investigate the relationship between preoperative FDG-PET parameters and the World Health Organization (WHO) classification or Masaoka staging system of thymic epithelial tumors.
METHODS: We retrospectively reviewed 32 patients with histologically proven thymic epithelial tumors who underwent FDG-PET/CT before surgical resection. FDG-PET parameters, including the maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolytic activity (TLG), were measured. These PET parameters were compared in the Masaoka staging system and WHO classification. A receiver operating characteristics (ROC) analysis was performed to identify the cut-off values of PET parameters for the accurate differentiation of early and advanced stages in the Masaoka staging system.
RESULTS: There were 17 low-risk thymomas (1 type A, 9 type AB, and 7 type B1), 8 high-risk thymomas (4 type B2 and 4 type B3), and 7 thymic carcinomas (7 squamous cell carcinoma). Their Masaoka stages were as follows: 24 in the early stage (stages I and II) and 8 in the advanced stage (stage III). Regarding the WHO classification, only SUVmax showed a significant difference (P < 0.05). In the Masaoka stage, all PET parameters were significantly higher in the advanced stage than in the early stage (P < 0.05). In the ROC analysis to predict the early and advanced stages in thymic epithelial tumors, the area under the curve was the highest for TLG among the PET parameters examined and the cut-off value of TLG for discriminating the early from advanced stage with maximal sensitivity and specificity was 30.735.
CONCLUSION: Although volumetric PET parameters, such as MTV and TLG, did not correlate with the WHO classification, a significant correlation was observed between SUVmax and the WHO classification. In the Masaoka staging system, volumetric PET parameters may achieve more precise staging than SUVmax.

Entities:  

Keywords:  fluorodeoxyglucose F18; positron emission tomography computed tomography; thymic epithelial tumor

Year:  2019        PMID: 30962757      PMCID: PMC6437411     

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  27 in total

1.  (18)F-FDG PET for the evaluation of thymic epithelial tumors: Correlation with the World Health Organization classification in addition to dual-time-point imaging.

Authors:  Atsuo Inoue; Noriyuki Tomiyama; Mitsuaki Tatsumi; Naoki Ikeda; Meinoshin Okumura; Hiroyuki Shiono; Masayoshi Inoue; Ichiro Higuchi; Katsuyuki Aozasa; Takeshi Johkoh; Hironobu Nakamura; Jun Hatazawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-14       Impact factor: 9.236

2.  Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.

Authors:  Kyoichi Kaira; Masahiro Endo; Masato Abe; Kazuo Nakagawa; Yasuhisa Ohde; Takehiro Okumura; Toshiaki Takahashi; Haruyasu Murakami; Asuka Tsuya; Yukiko Nakamura; Tateaki Naito; Isamu Hayashi; Masakuni Serizawa; Yasuhiro Koh; Hirofumi Hanaoka; Hideyuki Tominaga; Noboru Oriuchi; Haruhiko Kondo; Takashi Nakajima; Nobuyuki Yamamoto
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

3.  18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups.

Authors:  Yon Mi Sung; Kyung Soo Lee; Byung-Tae Kim; Joon Young Choi; Young Mog Shim; Chin A Yi
Journal:  J Nucl Med       Date:  2006-10       Impact factor: 10.057

4.  ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.

Authors:  Masatoyo Nakajo; Yoriko Kajiya; Atsushi Tani; Satoshi Yoneda; Hiroshi Shirahama; Michiyo Higashi; Masayuki Nakajo
Journal:  Eur J Radiol       Date:  2010-08-31       Impact factor: 3.528

5.  The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients.

Authors:  Meinoshin Okumura; Mitsunori Ohta; Hisashi Tateyama; Katsuhiro Nakagawa; Akihide Matsumura; Hajime Maeda; Hiroto Tada; Tadaaki Eimoto; Hikaru Matsuda; Akira Masaoka
Journal:  Cancer       Date:  2002-02-01       Impact factor: 6.860

6.  Thymoma: a clinicopathologic study based on the new World Health Organization classification.

Authors:  Kazuo Nakagawa; Hisao Asamura; Yoshihiro Matsuno; Kenji Suzuki; Haruhiko Kondo; Arafumi Maeshima; Etsuo Miyaoka; Ryosuke Tsuchiya
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

Review 7.  Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma.

Authors:  Alberto M Marchevsky; Ruta Gupta; Robert J McKenna; Mark Wick; Cesar Moran; Maureen F Zakowski; Saul Suster
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

8.  Role of fluorine-flurodeoxyglucose positron emission tomography/computed tomography in preoperative assessment of anterior mediastinal masses.

Authors:  Luca Luzzi; Andrea Campione; Alberto Gorla; Giuseppe Vassallo; Andrea Bianchi; Alberto Biggi; Alberto Terzi
Journal:  Eur J Cardiothorac Surg       Date:  2009-06-05       Impact factor: 4.191

9.  Characterization of thymic masses using (18)F-FDG PET-CT.

Authors:  Arvind Kumar; Subodh Kumar Regmi; Roman Dutta; Rakesh Kumar; Siddhartha Datta Gupta; Prasenjit Das; Dhanapathi Halanaik; Tarun Jindal
Journal:  Ann Nucl Med       Date:  2009-07-08       Impact factor: 2.668

10.  Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.

Authors:  Masahiro Endo; Kazuo Nakagawa; Yasuhisa Ohde; Takehiro Okumura; Haruhiko Kondo; Satoshi Igawa; Yukiko Nakamura; Asuka Tsuya; Haruyasu Murakami; Toshiaki Takahashi; Nobuyuki Yamamoto; Ichiro Ito; Toru Kameya
Journal:  Lung Cancer       Date:  2008-03-04       Impact factor: 5.705

View more
  4 in total

1.  Euclidean Geometry Versus Metabolic Biochemistry in the Prognostic Evaluation of Thymic Epithelial Tumors.

Authors:  Luca Bertolaccini; Lorenzo Spaggiari
Journal:  Ann Surg Oncol       Date:  2020-11-16       Impact factor: 5.344

2.  Total thymectomy for thymic lymphoepithelioma-like carcinoma-report of two cases.

Authors:  Sachi Kawagishi; Naoko Ose; Masato Minami; Soichiro Funaki; Takashi Kanou; Kenji Kimura; Seiji Taniguchi; Eiichi Morii; Yasushi Shintani
Journal:  Surg Case Rep       Date:  2019-10-26

3.  Diagnostic and prognostic value of FDG PET-CT in patients with suspected recurrent thymic epithelial tumors.

Authors:  Guozhu Hou; Yuanyuan Jiang; Fang Li; Wuying Cheng
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

4.  Dual-energy CT perfusion imaging for differentiating WHO subtypes of thymic epithelial tumors.

Authors:  Chunhai Yu; Ting Li; Ruiping Zhang; Xiaotang Yang; Zhao Yang; Lei Xin; Zhikai Zhao
Journal:  Sci Rep       Date:  2020-03-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.